Created at Source Raw Value Validated value
June 25, 2024, noon usa

inclusion criteria: 1. patients aged 50 years or older with a positive test for sars-cov2 in the past 5 days and eligible for ambulatory treatment. 2. presence of respiratory symptoms (i.e. cough, sore throat, or shortness of breath) or body temperature \>37.5° c. 3. ability of the patient to travel to the study center by private transportation, performed either by accompanying person from same household or by the patient him/herself 4. ability to comply with standard hygiene requirements at the time of in-hospital visit, including a face mask and hand disinfectant. 5. ability to walk from car to study center or reach it using a wheel chair transport with the help of an accompanying person from the same household also complying with standard hygiene requirements. 6. ability to self-administer prefilled enoxaparin injections after instructions received at the study center or availability of a person living with the patient to administer enoxaparin.

inclusion criteria: 1. patients aged 50 years or older with a positive test for sars-cov2 in the past 5 days and eligible for ambulatory treatment. 2. presence of respiratory symptoms (i.e. cough, sore throat, or shortness of breath) or body temperature \>37.5° c. 3. ability of the patient to travel to the study center by private transportation, performed either by accompanying person from same household or by the patient him/herself 4. ability to comply with standard hygiene requirements at the time of in-hospital visit, including a face mask and hand disinfectant. 5. ability to walk from car to study center or reach it using a wheel chair transport with the help of an accompanying person from the same household also complying with standard hygiene requirements. 6. ability to self-administer prefilled enoxaparin injections after instructions received at the study center or availability of a person living with the patient to administer enoxaparin.

Nov. 16, 2021, 6:30 p.m. usa

inclusion criteria: patients aged 50 years or older with a positive test for sars-cov2 in the past 5 days and eligible for ambulatory treatment. presence of respiratory symptoms (i.e. cough, sore throat, or shortness of breath) or body temperature >37.5° c. ability of the patient to travel to the study center by private transportation, performed either by accompanying person from same household or by the patient him/herself ability to comply with standard hygiene requirements at the time of in-hospital visit, including a face mask and hand disinfectant. ability to walk from car to study center or reach it using a wheel chair transport with the help of an accompanying person from the same household also complying with standard hygiene requirements. ability to self-administer prefilled enoxaparin injections after instructions received at the study center or availability of a person living with the patient to administer enoxaparin.

inclusion criteria: patients aged 50 years or older with a positive test for sars-cov2 in the past 5 days and eligible for ambulatory treatment. presence of respiratory symptoms (i.e. cough, sore throat, or shortness of breath) or body temperature >37.5° c. ability of the patient to travel to the study center by private transportation, performed either by accompanying person from same household or by the patient him/herself ability to comply with standard hygiene requirements at the time of in-hospital visit, including a face mask and hand disinfectant. ability to walk from car to study center or reach it using a wheel chair transport with the help of an accompanying person from the same household also complying with standard hygiene requirements. ability to self-administer prefilled enoxaparin injections after instructions received at the study center or availability of a person living with the patient to administer enoxaparin.

Oct. 26, 2020, 11:31 p.m. usa

inclusion criteria: 1. patients aged 50 years or older with a positive test for sars-cov2 in the past 5 days and eligible for ambulatory treatment. 2. presence of respiratory symptoms (i.e. cough, sore throat, or shortness of breath) or body temperature >37.5° c. 3. ability of the patient to travel to the study center by private transportation, performed either by accompanying person from same household or by the patient him/herself 4. ability to comply with standard hygiene requirements at the time of in-hospital visit, including a face mask and hand disinfectant. 5. ability to walk from car to study center or reach it using a wheel chair transport with the help of an accompanying person from the same household also complying with standard hygiene requirements. 6. ability to self-administer prefilled enoxaparin injections after instructions received at the study center or availability of a person living with the patient to administer enoxaparin.

inclusion criteria: 1. patients aged 50 years or older with a positive test for sars-cov2 in the past 5 days and eligible for ambulatory treatment. 2. presence of respiratory symptoms (i.e. cough, sore throat, or shortness of breath) or body temperature >37.5° c. 3. ability of the patient to travel to the study center by private transportation, performed either by accompanying person from same household or by the patient him/herself 4. ability to comply with standard hygiene requirements at the time of in-hospital visit, including a face mask and hand disinfectant. 5. ability to walk from car to study center or reach it using a wheel chair transport with the help of an accompanying person from the same household also complying with standard hygiene requirements. 6. ability to self-administer prefilled enoxaparin injections after instructions received at the study center or availability of a person living with the patient to administer enoxaparin.